Loading
Assistant Professor Dr. Verawan Uchaipichat

Assistant Professor Dr. Verawan Uchaipichat

เภสัชกรรมคลินิก,
Faculty of Pharmaceutical Sciences,
Khon Kaen University
6504565388: H-INDEX 11

Documents

TCI อ้างอิงจาก http://www.tci-thaijo.org/

0

SCOPUS

0

PUBMED

0

ISI

0

TCI

Title Author Year SCOPUS PUBMED ISI TCI
1. Human udp-glucuronosyltransferases: isoform selectivity and kinetics of 4-methylumbelliferone and 1-naphthol glucuronidation, effects of organic solvents, and inhibition by diclofenac and probenecid. V Uchaipichat
PI Mackenzie
XH Guo
D Gardner-Stephen
A Galetin
JB Houston
JO Miners
2004
2. Erratum: Human UDP-glucuronosyltransferases: Isoform selectivity and kinetics of 4-methylumbelliferone and 1-naphthol glucuronidation, effects of organic solvents, and inhibition by diclofenac and probenecid (Drug Metabolism Disposition (2004) 32 (413-423)) Uchaipichat, V. 2005
3. Human UDP-glucuronosyltransferases: Isoform selectivity and kinetics of 4-methylumbelliferone and 1-naphthol glucuronidation, effects of organic solvents, and inhibition by diclofenac and probenecid (vol 32, pg 413, 2004) V Uchaipichat
PI Mackenzie
XH Guo
D Gardner-Stephen
A Galetin
JB Houston
JO Miners
2005
4. Characterisation of interactions between UDP-glucuronosyltransferase 2B7 (UGT2B7) substrates using multisite kinetic modelling Verawan Uchaipichat
Peter Mackenzie
Brian Houston
Aleksandra Galetin
John Miners
2006
5. Multisite kinetic modelling of interactions between UDP-glucuronosyltransferase 2B7 (UGT2B7) substrates Aleksandra Galetin
Verawan Uchaipichat
Peter I. Mackenzie
J. Brian Houston
John O. Miners
2006
6. Quantitative prediction of in vivo inhibitory interactions involving glucuronidated drugs from in vitro data: the effect of fluconazole on zidovudine glucuronidation Uchaipichat, V.
Winner, L.K.
2006
7. Relationship between hyperbilirubinaemia and UDP-glucuronosyltransferase 1A1 (UGT1A1) polymorphism in adult HIV-infected Thai patients treated with indinavir MA Boyd
P Srasuebkul
K Ruxrungtham
PI Mackenzie
V Uchaipichat
M Stek
JMA Lange
P Phanuphak
DA Cooper
W Udomuksorn
JO Miners
2006
8. Selectivity of substrate (trifluoperazine) and inhibitor (amitriptyline, androsterone, canrenoic acid, hecogenin, phenylbutazone, quinidine, quinine, and sulfinpyrazone) "probes" for human udp-glucuronosyltransferases. V Uchaipichat
PI Mackenzie
DJ Elliot
JO Miners
2006
9. UNRAVELLING THE KINETIC ANOMALIES OF UDP-GLUCURONOSYLTRANSFERASES John O. Miners
Andrew Rowland
Verawan Uchaipichat
David J. Elliot
Kathleen M. Knights
Peter I. Mackenzie
2007
10. Adverse Drug Reaction Monitoring to Antiepileptic Drugs by Patient Self Reports Piyanida Senacom
Narumol Jarernsiripornkul
Verawan Uchaipichat
2008
11. Kinetic modeling of the interactions between 4-methylumbelliferone, 1-naphthol, and zidovudine glucuronidation by UDP-glucuronosyltransferase 2B7 (UGT2B7) provides evidence for multiple substrate binding and effector sites Uchaipichat, V. 2008
12. The smoothness of blood pressure control of ramipril in essential hypertensive Thai patients evaluation by 24-hour ambulatory blood pressure monitoring. Uchaipichat, V.
Koanantakul, B.
2008
13. Albumin Effect on In Vitro Codeine (COD) Glucuronidation: Improving the Prediction of Hepatic Intrinsic Clearance Pritsana Raungrut
Benjamas Janchawee
Verawan Uchaipichat
David J. Elliot
John O. Miners
2009
14. Development of a High Performance Liquid Chromatography with Coulometric Electrochemical Detector Method for the Analysis of Morphine in Human Plasma Thanee Tessiri
Viroj Sumyai
Suvatana Chulavatnatol
Poj Kulvanich
Khanittha Tontisirin
Thaned Pongjanyakul
Sirikul Aumpon
Verawan Uchaipichat
Detpon Preechagoon
2009
15. Inhibition of codeine glucuronidation in vitro by fluconazole, ketamine, ketoconazole and valproic acid: Prediction of in vivo drug-drug interaction potential John O. Miners
Pritsana Raungrut
Verawan Uchaipichat
David J. Elliot
Benjamas Janchawee
2009
16. Effect of Albumin on Human Cytochromes P450 Kinetics: Extrapolation of in Vivo Clearance from in Vitro Data Nitsupa Wattanachai
David J. Elliot
Verawan Uchaipichat
Wichittra Tassaneeyakul
John O. Miners
2010
17. Effects of Andrographis paniculata and Orthosiphon stamineus Extracts on the Glucuronidation of 4-Methylumbelliferone in Human UGT Isoforms Hanapi, N.A.
Ab Halim, M.R.
Uchaipichat, V.
2010
18. Formulation development of morphine sulfate sustained-release tablets and its bioequivalence study in healthy Thai volunteers. Detpon Preechagoon
Viroj Sumyai
Suvatna Chulavatnatol
Poj Kulvanich
Thanee Tessiri
Khanittha Tontisirin
Thaned Pongjanyakul
Verawan Uchaipichat
Sirikul Aumpon
Chaiyasit Wongvipaporn
2010
19. In vitro-in vivo extrapolation predicts drug-drug interactions arising from inhibition of codeine glucuronidation by dextropropoxyphene, fluconazole, ketoconazole, and methadone in humans Raungrut, P
Uchaipichat, V
Elliot, DJ
Janchawee, B
Somogyi, AA
Miners, JO
2010
20. Kinetic and Enzymatic Characterisation of Human Hepatic R- and S- Lorazepam Glucuronidation Verawan Uchaipichat
Chuthamanee Suthisisang
Peter I. Mackenzie
John O. Miners
2010
21. The Albumin Effect on In vitro Kinetics of Various Cytochrome P450-Catalyzed Reactions: In vitro to In vivo Extrapolation Nitsupa Wattanachai
Wichittra Tassaneeyakul
Verawan Uchaipichat
John O. Miners
2010
22. Effects of ketamine on human UDP-glucuronosyltransferases in vitro predict potential drug-drug interactions arising from ketamine inhibition of codeine and morphine glucuronidation. Verawan Uchaipichat
Pritsana Raungrut
Nuy Chau
Benjamas Janchawee
Allan M. Evans
John O. Miners
2011
23. In vitro approaches for the prediction of inhibition of drug glucuronidation clearance in humans Verawan Uchaipichat
Peter I. Mackenzie
John O. Miners
2011
24. In vitro-in vivo extrapolation of CYP2C8-catalyzed paclitaxel 6α-hydroxylation: effects of albumin on in vitro kinetic parameters and assessment of interindividual variability in predicted clearance. Nitsupa Wattanachai
Thomas M. Polasek
Tahlia M. Heath
Verawan Uchaipichat
Wongwiwat Tassaneeyakul
Wichittra Tassaneeyakul
John O. Miners
2011
25. In vitro - in vivo extrapolation predicts a potential metabolic drug-drug interaction between ketamine and morphine Verawan Uchaipichat
Nuy Chau
Pritsana Raungrut
Benjamas Janchawee
Peter Mackenzie
John Miners
2011
26. Patient reporting of suspected adverse drug reactions to antiepileptic drugs: Factors affecting attribution accuracy Jarernsiripornkul, N.
Senacom, P.
Uchaipichat, V.
Chaipichit, N.
Krska, J.
2012
27. The Glucuronidation of R- and S-Lorazepam: Human Liver Microsomal Kinetics, UDP-Glucuronosyltransferase Enzyme Selectivity, and Inhibition by Drugs Uchaipichat, V. 2013
28. A qualitative study to explore how patients identify and assess symptoms as adverse drug reactions. Nataporn Chaipichit
Janet Krska
Thongchai Pratipanawatr
Verawan Uchaipichat
Narumol Jarernsiripornkul
2014
29. Patients' Attitude Towards Self-Reporting of Adverse Drug Reactions Nataporn Chaipichit
Narumol Jarernsiripornkul
Verawan Uchaipichat
Thongchai Pratipanawatr
Janet Krska
2014
30. Experiences of adverse drug effects reported by patients in ambulatory clinic Narumol Jarernsiripornkul
Nataporn Chaipichit
Janet Krska
Verawan Uchaipichat
Thongchai Pratipanawatr
2015
31. Introducing self-reporting questionnaires about adverse drug reactions to patients: attitude towards their first experience Nataporn Chaipichit
Narumol Jarernsiripornkul
Verawan Uchaipichat
Thongchai Pratipanawatr
Janet Krska
2015
32. Initial development and testing of an instrument for patient self-assessment of adverse drug reactions Jarernsiripornkul, N.
Chaipichit, N.
Pratipanawatr, T.
Uchaipichat, V.
Krska, J.
2016
33. Prevalence of Potential Statin-Drug Interactions in Dyslipidemic Patients at Srinagarind Hospital Jantira Roddech
Panadchanun Phiwbang
Panjittra Kitirach
Patcharin Nisanggad
Pansu Sriangkan
Chaiyasith Wongvipaporn
Verawan Uchaipichat
2016
34. Warfarin using knowledge and international normalized ratio goal control in outpatients of Queen Sirikit heart center of the northeast Pattavee Loharattanakong
Ploypilin Ritthiboon
Yuwatida Hongrinya
Maneepimai Chaichun
Suthep Taksinachanekij
Verawan Uchaipichat
2016
35. Prevalence of potential drug interactions in Thai patients receiving simvastatin: The causality assessment of musculoskeletal adverse events induced by statin interaction. Methira Siriangkhawut
Patthana Tansakul
Verawan Uchaipichat
2017
36. In vitro inhibitory effects of major bioactive constituents of Andrographis paniculata, Curcuma longa and Silybum marianum on human liver microsomal morphine glucuronidation: A prediction of potential herb-drug interactions arising from andrographolide, curcumin and silybin inhibition in humans Verawan Uchaipichat 2018
37. In vitro inhibitory effects of major bioactive constituents of Andrographis paniculata, Curcuma longa and Silybum marianum on human liver microsomal morphine glucuronidation: A prediction of potential herb-drug interactions arising from andrographolide, curcumin and silybin inhibition in humans. Uchaipichat, V 2018
Count 18 17 28 6

Title Authors Year Publication name Cited count
< 2015 2016 2017 2018 2019 2020 Total
1. Human UDP-glucuronosyltransferases: Isoform selectivity and kinetics of 4-methylumbelliferone and 1-naphthol glucuronidation, effects of organic solvents, and inhibition by diclofenac and probenecid Uchaipichat, V. 2004 Drug Metabolism and Disposition
4 (32), pp. 413-423
2. Erratum: Human UDP-glucuronosyltransferases: Isoform selectivity and kinetics of 4-methylumbelliferone and 1-naphthol glucuronidation, effects of organic solvents, and inhibition by diclofenac and probenecid (Drug Metabolism Disposition (2004) 32 (413-423)) Uchaipichat, V. 2005 Drug Metabolism and Disposition
12 (33), pp. 1925-1926
3. Quantitative prediction of in vivo inhibitory interactions involving glucuronidated drugs from in vitro data: The effect of fluconazole on zidovudine glucuronidation Uchaipichat, V.
Winner, L.K.
2006 British Journal of Clinical Pharmacology
4 (61), pp. 427-439
4. Relationship between hyperbilirubinaemia and UDP-glucuronosyltransferase 1A1 (UGT1A1) polymorphism in adult HIV-infected Thai patients treated with indinavir Srasuebkul, P.
Ruxrungtham, K.
Uchaipichat, V.
Phanuphak, P.P.
Cooper, D.A.
Udomuksorn, W.
2006 Pharmacogenetics and Genomics
5 (16), pp. 321-329
5. Selectivity of substrate (trifluoperazine) and inhibitor (amitriptyline, androsterone, canrenoic acid, hecogenin, phenylbutazone, quinidine, quinine, and sulfinpyrazone) "probes" for human UDP-glucuronosyltransferases Uchaipichat, V. 2006 Drug Metabolism and Disposition
3 (34), pp. 449-456
6. Kinetic modeling of the interactions between 4-methylumbelliferone, 1-naphthol, and zidovudine glucuronidation by UDP-glucuronosyltransferase 2B7 (UGT2B7) provides evidence for multiple substrate binding and effector sites Uchaipichat, V. 2008 Molecular Pharmacology
4 (74), pp. 1152-1162
7. The smoothness of blood pressure control of ramipril in essential hypertensive Thai patients evaluation by 24-hour ambulatory blood pressure monitoring Uchaipichat, V.
Koanantakul, B.
2008 Journal of the Medical Association of Thailand
9 (91), pp. 1468-1477
8. Effects of Andrographispaniculata and Orthosiphon stamineus extracts on the glucuronidation of 4-methylumbelliferone in human UGT isoforms Hanapi, N.A.
Ab Halim, M.R.
Uchaipichat, V.
2010 Molecules
5 (15), pp. 3578-3592
9. Formulation development of morphine sulfate sustained-release tablets and its bioequivalence study in healthy thai volunteers Preechagoon, D.
Tessiri, T.
Pongjanyakul, T.
Uchaipichat, V.
Wongvipaporn, C.
2010 AAPS PharmSciTech
3 (11), pp. 1449-1455
10. In vitro-in vivo extrapolation predicts drug-drug interactions arising from inhibition of codeine glucuronidation by dextropropoxyphene, fluconazole, ketoconazole, and methadone in humans Uchaipichat, V.
Janchawee, B.
2010 Journal of Pharmacology and Experimental Therapeutics
2 (334), pp. 609-618
11. Effects of ketamine on human UDP-glucuronosyltransferases in vitro predict potential drug-drug interactions arising from ketamine inhibition of codeine and morphine glucuronidation Uchaipichat, V.
Janchawee, B.
2011 Drug Metabolism and Disposition
8 (39), pp. 1324-1328
12. In vitro-in vivo extrapolation of CYP2C8-catalyzed paclitaxel 6α-hydroxylation: Effects of albumin on in vitro kinetic parameters and assessment of interindividual variability in predicted clearance Wattanachai, N.
Uchaipichat, V.
Tassaneeyakul, W.
Tassaneeyakul, W.
2011 European Journal of Clinical Pharmacology
8 (67), pp. 815-824
13. Patient reporting of suspected adverse drug reactions to antiepileptic drugs: Factors affecting attribution accuracy Jarernsiripornkul, N.
Senacom, P.
Uchaipichat, V.
Chaipichit, N.
Krska, J.
2012 Epilepsy and Behavior
1 (24), pp. 102-106
14. The glucuronidation of R- and S-lorazepam: Human liver microsomal kinetics, UDP-glucuronosyltransferase enzyme selectivity, and inhibition by drugs Uchaipichat, V. 2013 Drug Metabolism and Disposition
6 (41), pp. 1273-1284
15. A qualitative study to explore how patients identify and assess symptoms as adverse drug reactions Chaipichit, N.
Krska, J.
Pratipanawatr, T.
Uchaipichat, V.
Jarernsiripornkul, N.
2014 European Journal of Clinical Pharmacology
5 (70), pp. 607-615
16. Initial development and testing of an instrument for patient self-assessment of adverse drug reactions Jarernsiripornkul, N.
Chaipichit, N.
Pratipanawatr, T.
Uchaipichat, V.
Krska, J.
2016 Pharmacoepidemiology and Drug Safety
1 (25), pp. 54-63
17. Prevalence of potential drug interactions in Thai patients receiving simvastatin: The causality assessment of musculoskeletal adverse events induced by statin interaction Uchaipichat, V. 2017 Saudi Pharmaceutical Journal
6 (25), pp. 823-829
18. In vitro inhibitory effects of major bioactive constituents of Andrographis paniculata, Curcuma longa and Silybum marianum on human liver microsomal morphine glucuronidation: A prediction of potential herb-drug interactions arising from andrographolide, curcumin and silybin inhibition in humans Uchaipichat, V. 2018 Drug Metabolism and Pharmacokinetics
1 (33), pp. 67-76

Title Authors Year Journal title
1. Human udp-glucuronosyltransferases: isoform selectivity and kinetics of 4-methylumbelliferone and 1-naphthol glucuronidation, effects of organic solvents, and inhibition by diclofenac and probenecid. Uchaipichat, V
Mackenzie, PI
Guo, XH
Gardner-Stephen, D
Galetin, A
Houston, JB
Miners, JO
2004 Drug metabolism and disposition: the biological fate of chemicals
4 (32), pp. 413-23
2. Quantitative prediction of in vivo inhibitory interactions involving glucuronidated drugs from in vitro data: the effect of fluconazole on zidovudine glucuronidation. Uchaipichat, V
Winner, LK
Mackenzie, PI
Elliot, DJ
Williams, JA
Miners, JO
2006 British journal of clinical pharmacology
4 (61), pp. 427-39
3. Relationship between hyperbilirubinaemia and UDP-glucuronosyltransferase 1A1 (UGT1A1) polymorphism in adult HIV-infected Thai patients treated with indinavir. Boyd, MA
Srasuebkul, P
Ruxrungtham, K
Mackenzie, PI
Uchaipichat, V
Stek, M
Lange, JM
Phanuphak, P
Cooper, DA
Udomuksorn, W
Miners, JO
2006 Pharmacogenetics and genomics
5 (16), pp. 321-9
4. Selectivity of substrate (trifluoperazine) and inhibitor (amitriptyline, androsterone, canrenoic acid, hecogenin, phenylbutazone, quinidine, quinine, and sulfinpyrazone) "probes" for human udp-glucuronosyltransferases. Uchaipichat, V
Mackenzie, PI
Elliot, DJ
Miners, JO
2006 Drug metabolism and disposition: the biological fate of chemicals
3 (34), pp. 449-56
5. The smoothness of blood pressure control of ramipril in essential hypertensive Thai patients evaluation by 24-hour ambulatory blood pressure monitoring. Uchaipichat, V
Koanantakul, B
Suthisisang, C
2008 Journal of the Medical Association of Thailand = Chotmaihet thangphaet
9 (91), pp. 1468-77
6. Kinetic modeling of the interactions between 4-methylumbelliferone, 1-naphthol, and zidovudine glucuronidation by udp-glucuronosyltransferase 2B7 (UGT2B7) provides evidence for multiple substrate binding and effector sites. Uchaipichat, V
Galetin, A
Houston, JB
Mackenzie, PI
Williams, JA
Miners, JO
2008 Molecular pharmacology
4 (74), pp. 1152-62
7. In vitro-in vivo extrapolation predicts drug-drug interactions arising from inhibition of codeine glucuronidation by dextropropoxyphene, fluconazole, ketoconazole, and methadone in humans. Raungrut, P
Uchaipichat, V
Elliot, DJ
Janchawee, B
Somogyi, AA
Miners, JO
2010 The Journal of pharmacology and experimental therapeutics
2 (334), pp. 609-18
8. Effects of Andrographis paniculata and Orthosiphon stamineus extracts on the glucuronidation of 4-methylumbelliferone in human UGT isoforms. Ismail, S
Hanapi, NA
Ab Halim, MR
Uchaipichat, V
Mackenzie, PI
2010 Molecules (Basel, Switzerland)
5 (15), pp. 3578-92
9. Formulation development of morphine sulfate sustained-release tablets and its bioequivalence study in healthy Thai volunteers. Preechagoon, D
Sumyai, V
Chulavatnatol, S
Kulvanich, P
Tessiri, T
Tontisirin, K
Pongjanyakul, T
Uchaipichat, V
Aumpon, S
Wongvipaporn, C
2010 AAPS PharmSciTech
3 (11), pp. 1449-55
10. Effects of ketamine on human UDP-glucuronosyltransferases in vitro predict potential drug-drug interactions arising from ketamine inhibition of codeine and morphine glucuronidation. Uchaipichat, V
Raungrut, P
Chau, N
Janchawee, B
Evans, AM
Miners, JO
2011 Drug metabolism and disposition: the biological fate of chemicals
8 (39), pp. 1324-8
11. In vitro-in vivo extrapolation of CYP2C8-catalyzed paclitaxel 6α-hydroxylation: effects of albumin on in vitro kinetic parameters and assessment of interindividual variability in predicted clearance. Wattanachai, N
Polasek, TM
Heath, TM
Uchaipichat, V
Tassaneeyakul, W
Tassaneeyakul, W
Miners, JO
2011 European journal of clinical pharmacology
8 (67), pp. 815-24
12. Patient reporting of suspected adverse drug reactions to antiepileptic drugs: factors affecting attribution accuracy. Jarernsiripornkul, N
Senacom, P
Uchaipichat, V
Chaipichit, N
Krska, J
2012 Epilepsy & behavior : E&B
1 (24), pp. 102-6
13. The glucuronidation of R- and S-lorazepam: human liver microsomal kinetics, UDP-glucuronosyltransferase enzyme selectivity, and inhibition by drugs. Uchaipichat, V
Suthisisang, C
Miners, JO
2013 Drug metabolism and disposition: the biological fate of chemicals
6 (41), pp. 1273-84
14. A qualitative study to explore how patients identify and assess symptoms as adverse drug reactions. Chaipichit, N
Krska, J
Pratipanawatr, T
Uchaipichat, V
Jarernsiripornkul, N
2014 European journal of clinical pharmacology
5 (70), pp. 607-15
15. Initial development and testing of an instrument for patient self-assessment of adverse drug reactions. Jarernsiripornkul, N
Chaipichit, N
Pratipanawatr, T
Uchaipichat, V
Krska, J
2016 Pharmacoepidemiology and drug safety
1 (25), pp. 54-63
16. Prevalence of potential drug interactions in Thai patients receiving simvastatin: The causality assessment of musculoskeletal adverse events induced by statin interaction. Siriangkhawut, M
Tansakul, P
Uchaipichat, V
2017 Saudi pharmaceutical journal : SPJ : the official publication of the Saudi Pharmaceutical Society
6 (25), pp. 823-829
17. In vitro inhibitory effects of major bioactive constituents of Andrographis paniculata, Curcuma longa and Silybum marianum on human liver microsomal morphine glucuronidation: A prediction of potential herb-drug interactions arising from andrographolide, curcumin and silybin inhibition in humans. Uchaipichat, V 2018 Drug metabolism and pharmacokinetics
1 (33), pp. 67-76

Title Authors Year Journal title Cited count
< 2015 2016 2017 2018 2019 2020 Total
1. Human UDP-glucuronosyltransferases: Isoform selectivity and kinetics of 4-methylumbelliferone and 1-naphthol glucuronidation, effects of organic solvents, and inhibition by diclofenac and probenecid V Uchaipichat
PI Mackenzie
XH Guo
D Gardner-Stephen
A Galetin
JB Houston
JO Miners
2004 DRUG METABOLISM AND DISPOSITION
4.0 (32.0), pp. 413.0-423.0
226 0 0 0 0 0 226
2. Human UDP-glucuronosyltransferases: Isoform selectivity and kinetics of 4-methylumbelliferone and 1-naphthol glucuronidation, effects of organic solvents, and inhibition by diclofenac and probenecid (vol 32, pg 413, 2004) V Uchaipichat
PI Mackenzie
XH Guo
D Gardner-Stephen
A Galetin
JB Houston
JO Miners
2005 DRUG METABOLISM AND DISPOSITION
12.0 (33.0), pp. 1925.0-1926.0
1 0 0 0 0 0 1
3. Characterisation of interactions between UDP-glucuronosyltransferase 2B7 (UGT2B7) substrates using multisite kinetic modelling Verawan Uchaipichat
Peter Mackenzie
Brian Houston
Aleksandra Galetin
John Miners
2006 ACTA PHARMACOLOGICA SINICA
(27.0), pp. 218.0-218.0
0 0 0 0 0 0 0
4. Multisite kinetic modelling of interactions between UDP-glucuronosyltransferase 2B7 (UGT2B7) substrates Aleksandra Galetin
Verawan Uchaipichat
Peter I. Mackenzie
J. Brian Houston
John O. Miners
2006 DRUG METABOLISM REVIEWS
(38.0), pp. 45.0-46.0
0 0 0 0 0 0 0
5. Quantitative prediction of in vivo inhibitory interactions involving glucuronidated drugs from in vitro data: the effect of fluconazole on zidovudine glucuronidation V Uchaipichat
LK Winner
PI Mackenzie
DJ Elliot
JA Williams
JO Miners
2006 BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
4.0 (61.0), pp. 427.0-439.0
119 0 0 0 0 0 119
6. Relationship between hyperbilirubinaemia and UDP-glucuronosyltransferase 1A1 (UGT1A1) polymorphism in adult HIV-infected Thai patients treated with indinavir MA Boyd
P Srasuebkul
K Ruxrungtham
PI Mackenzie
V Uchaipichat
M Stek
JMA Lange
P Phanuphak
DA Cooper
W Udomuksorn
JO Miners
2006 PHARMACOGENETICS AND GENOMICS
5.0 (16.0), pp. 321.0-329.0
33 0 0 0 0 0 33
7. Selectivity of substrate (trifluoperazine) and inhibitor (amitriptyline, androsterone, canrenoic acid, hecogenin, phenylbutazone, quinidine, quinine, and sulfinpyrazone) probes for human UDP- glucuronosyltransferases V Uchaipichat
PI Mackenzie
DJ Elliot
JO Miners
2006 DRUG METABOLISM AND DISPOSITION
3.0 (34.0), pp. 449.0-456.0
161 0 0 0 0 0 161
8. UNRAVELLING THE KINETIC ANOMALIES OF UDP-GLUCURONOSYLTRANSFERASES John O. Miners
Andrew Rowland
Verawan Uchaipichat
David J. Elliot
Kathleen M. Knights
Peter I. Mackenzie
2007 DRUG METABOLISM REVIEWS
(39.0), pp. 11.0-11.0
0 0 0 0 0 0 0
9. Kinetic modeling of the interactions between 4-methylumbelliferone, 1-naphthol, and zidovudine glucuronidation by UDP-glucuronosyltransferase 2B7 (UGT2B7) provides evidence for multiple substrate binding and effector sites Verawan Uchaipichat
Aleksandra Galetin
J. Brian Houston
Peter I. Mackenzie
J. Andrew Williams
John O. Miners
2008 MOLECULAR PHARMACOLOGY
4.0 (74.0), pp. 1152.0-1162.0
42 0 0 0 0 0 42
10. Albumin Effect on In Vitro Codeine (COD) Glucuronidation: Improving the Prediction of Hepatic Intrinsic Clearance Pritsana Raungrut
Benjamas Janchawee
Verawan Uchaipichat
David J. Elliot
John O. Miners
2009 DRUG METABOLISM REVIEWS
(41.0), pp. 100.0-101.0
0 0 0 0 0 0 0
11. Inhibition of codeine glucuronidation in vitro by fluconazole, ketamine, ketoconazole and valproic acid: Prediction of in vivo drug-drug interaction potential John O. Miners
Pritsana Raungrut
Verawan Uchaipichat
David J. Elliot
Benjamas Janchawee
2009 DRUG METABOLISM REVIEWS
(41.0), pp. 76.0-76.0
0 0 0 0 0 0 0
12. Effects of Andrographis paniculata and Orthosiphon stamineus Extracts on the Glucuronidation of 4-Methylumbelliferone in Human UGT Isoforms Sabariah Ismail
Nur Aziah Hanapi
Mohd Rohaimi Ab Halim
Verawan Uchaipichat
Peter I. Mackenzie
2010 MOLECULES
5.0 (15.0), pp. 3578.0-3592.0
8 0 0 0 0 0 8
13. Formulation Development of Morphine Sulfate Sustained-Release Tablets and Its Bioequivalence Study in Healthy Thai Volunteers Detpon Preechagoon
Viroj Sumyai
Suvatna Chulavatnatol
Poj Kulvanich
Thanee Tessiri
Khanittha Tontisirin
Thaned Pongjanyakul
Verawan Uchaipichat
Sirikul Aumpon
Chaiyasit Wongvipaporn
2010 AAPS PHARMSCITECH
3.0 (11.0), pp. 1449.0-1455.0
2 0 0 0 0 0 2
14. In Vitro-In Vivo Extrapolation Predicts Drug-Drug Interactions Arising from Inhibition of Codeine Glucuronidation by Dextropropoxyphene, Fluconazole, Ketoconazole, and Methadone in Humans Pritsana Raungrut
Verawan Uchaipichat
David J. Elliot
Benjamas Janchawee
Andrew A. Somogyi
John O. Miners
2010 JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
2.0 (334.0), pp. 609.0-618.0
91 0 0 0 0 0 91
15. Kinetic and Enzymatic Characterisation of Human Hepatic R- and S- Lorazepam Glucuronidation Verawan Uchaipichat
Chuthamanee Suthisisang
Peter I. Mackenzie
John O. Miners
2010 DRUG METABOLISM REVIEWS
(42.0), pp. 64.0-65.0
0 0 0 0 0 0 0
16. The Albumin Effect on In vitro Kinetics of Various Cytochrome P450-Catalyzed Reactions: In vitro to In vivo Extrapolation Nitsupa Wattanachai
Wichittra Tassaneeyakul
Verawan Uchaipichat
John O. Miners
2010 DRUG METABOLISM REVIEWS
(42.0), pp. 77.0-78.0
0 0 0 0 0 0 0
17. Effects of Ketamine on Human UDP-Glucuronosyltransferases In Vitro Predict Potential Drug-Drug Interactions Arising from Ketamine Inhibition of Codeine and Morphine Glucuronidation Verawan Uchaipichat
Pritsana Raungrut
Nuy Chau
Benjamas Janchawee
Allan M. Evans
John O. Miners
2011 DRUG METABOLISM AND DISPOSITION
8.0 (39.0), pp. 1324.0-1328.0
34 0 0 0 0 0 34
18. In vitro approaches for the prediction of inhibition of drug glucuronidation clearance in humans Verawan Uchaipichat
Peter I. Mackenzie
John O. Miners
2011 DRUG METABOLISM REVIEWS
(43.0), pp. 20.0-20.0
0 0 0 0 0 0 0
19. In vitro-in vivo extrapolation of CYP2C8-catalyzed paclitaxel 6 alpha-hydroxylation: effects of albumin on in vitro kinetic parameters and assessment of interindividual variability in predicted clearance Nitsupa Wattanachai
Thomas M. Polasek
Tahlia M. Heath
Verawan Uchaipichat
Wongwiwat Tassaneeyakul
Wichittra Tassaneeyakul
John O. Miners
2011 EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY
8.0 (67.0), pp. 815.0-824.0
46 0 0 0 0 0 46
20. In vitro - in vivo extrapolation predicts a potential metabolic drug-drug interaction between ketamine and morphine Verawan Uchaipichat
Nuy Chau
Pritsana Raungrut
Benjamas Janchawee
Peter Mackenzie
John Miners
2011 JOURNAL OF PHARMACOLOGICAL SCIENCES
(115.0), pp. 285P-285P
0 0 0 0 0 0 0
21. Patient reporting of suspected adverse drug reactions to antiepileptic drugs: Factors affecting attribution accuracy Narumol Jarernsiripornkul
Piyanida Senacom
Verawan Uchaipichat
Nataporn Chaipichit
Janet Krska
2012 EPILEPSY & BEHAVIOR
1.0 (24.0), pp. 102.0-106.0
13 0 0 0 0 0 13
22. The Glucuronidation of R- and S-Lorazepam: Human Liver Microsomal Kinetics, UDP-Glucuronosyltransferase Enzyme Selectivity, and Inhibition by Drugs Verawan Uchaipichat
Chuthamanee Suthisisang
John O. Miners
2013 DRUG METABOLISM AND DISPOSITION
6.0 (41.0), pp. 1273.0-1284.0
26 0 0 0 0 0 26
23. A qualitative study to explore how patients identify and assess symptoms as adverse drug reactions Nataporn Chaipichit
Janet Krska
Thongchai Pratipanawatr
Verawan Uchaipichat
Narumol Jarernsiripornkul
2014 EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY
5.0 (70.0), pp. 607.0-615.0
34 0 0 0 0 0 34
24. Experiences of adverse drug effects reported by patients in ambulatory clinic Narumol Jarernsiripornkul
Nataporn Chaipichit
Janet Krska
Verawan Uchaipichat
Thongchai Pratipanawatr
2015 INTERNATIONAL JOURNAL OF CLINICAL PHARMACY
1.0 (37.0), pp. 213.0-213.0
0 0 0 0 0 0 0
25. Introducing self-reporting questionnaires about adverse drug reactions to patients: attitude towards their first experience Nataporn Chaipichit
Narumol Jarernsiripornkul
Verawan Uchaipichat
Thongchai Pratipanawatr
Janet Krska
2015 INTERNATIONAL JOURNAL OF CLINICAL PHARMACY
1.0 (37.0), pp. 224.0-225.0
0 0 0 0 0 0 0
26. Initial development and testing of an instrument for patient self-assessment of adverse drug reactions Narumol Jarernsiripornkul
Nataporn Chaipichit
Thongchai Pratipanawatr
Verawan Uchaipichat
Janet Krska
2016 PHARMACOEPIDEMIOLOGY AND DRUG SAFETY
1.0 (25.0), pp. 54.0-63.0
6 0 0 0 0 0 6
27. Prevalence of potential drug interactions in Thai patients receiving simvastatin: The causality assessment of musculoskeletal adverse events induced by statin interaction Methira Siriangkhawut
Patthana Tansakul
Verawan Uchaipichat
2017 SAUDI PHARMACEUTICAL JOURNAL
6.0 (25.0), pp. 823.0-829.0
5 0 0 0 0 0 5
28. In vitro inhibitory effects of major bioactive constituents of Andrographis paniculata, Curcuma longa and Silybum marianum on human liver microsomal morphine glucuronidation: A prediction of potential herb-drug interactions arising from andrographolide, curcumin and silybin inhibition in humans Verawan Uchaipichat 2018 DRUG METABOLISM AND PHARMACOKINETICS
1.0 (33.0), pp. 67.0-76.0
4 0 0 0 0 0 4

Title Authors Year Journal title
1. Adverse Drug Reaction Monitoring to Antiepileptic Drugs by Patient Self Reports Piyanida Senacom
Narumol Jarernsiripornkul
Verawan Uchaipichat
2008 Srinagarind Medical Journal
(23 No 4), pp. 373-382
2. Development of a High Performance Liquid Chromatography with Coulometric Electrochemical Detector Method for the Analysis of Morphine in Human Plasma Thanee Tessiri
Viroj Sumyai
Suvatana Chulavatnatol
Poj Kulvanich
Khanittha Tontisirin
Thaned Pongjanyakul
Sirikul Aumpon
Verawan Uchaipichat
Detpon Preechagoon
2009 Isan Journal of Pharmaceutical Sciences
(5 No 2), pp. 123-130
3. Effect of Albumin on Human Cytochromes P450 Kinetics: Extrapolation of in Vivo Clearance from in Vitro Data Nitsupa Wattanachai
David J. Elliot
Verawan Uchaipichat
Wichittra Tassaneeyakul
John O. Miners
2010 Thai Journal of Pharmacology
(32 No 1), pp. 246-249
4. Patients' Attitude Towards Self-Reporting of Adverse Drug Reactions Nataporn Chaipichit
Narumol Jarernsiripornkul
Verawan Uchaipichat
Thongchai Pratipanawatr
Janet Krska
2014 Srinagarind Medical Journal
(29 No 5), pp. 461-468
5. Warfarin using knowledge and international normalized ratio goal control in outpatients of Queen Sirikit heart center of the northeast Pattavee Loharattanakong
Ploypilin Ritthiboon
Yuwatida Hongrinya
Maneepimai Chaichun
Suthep Taksinachanekij
Verawan Uchaipichat
2016 Srinagarind Medical Journal
(31 No 3), pp. 257-265
6. Prevalence of Potential Statin-Drug Interactions in Dyslipidemic Patients at Srinagarind Hospital Jantira Roddech
Panadchanun Phiwbang
Panjittra Kitirach
Patcharin Nisanggad
Pansu Sriangkan
Chaiyasith Wongvipaporn
Verawan Uchaipichat
2016 Srinagarind Medical Journal
(31 No 5), pp. 92-96

Title Authors NRIIS type Year NRIIS Scholarship

0.018636465072631836